Physician profile
Vikas Sharma
NPI 1619282225
$13,607.37
in general payments reported to CMS, 2019-2025
9 companies · $2,099 in 2025
The $2,099 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2021: $6,363 · 2022: $1,028 · 2023: $2,337 · 2024: $135 · 2025: $2,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,572 · Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,572.15 |
| Food and Beverage | $998.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,021.29 | 2021 | |
| Edwards Lifesciences Corporation | $3,314.19 | 2023-2025 | Pascal, Evoque |
| Atricure, INC. | $1,367.92 | 2019-2021 | |
| Abbott Laboratories | $1,049.15 | 2022-2025 | Triclip |
| Boston Scientific Corporation | $1,011.86 | 2022 | |
| Artivion, INC. | $619.11 | 2019-2021 | |
| Medtronic, INC. | $223.85 | 2023 | Corevalve Evolut R |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.